Author: RENEE TWOMBLY, p. 1, 8-9. Since 1965, entrepreneurs have struggled to find a way to capitalize on the enzyme's anti-inflammatory properties Immunologist Mark Saifer was sure, even before it had a name, that the peculiar emerald-green protein could reduce inflammation. But Saifer and the other scientists who have acted on that conviction to build up DDI Pharmaceuticals Inc. of Mountain View, Calif., couldn't say why the protein, derived from bovine testicles, worked, much less how it c

A husband-and-wife team and their biotech firm rush to develop medicine that will stop allergic reactions before they even begin The allergy market is nothing to sneeze at. Consumers spend millions of dollars annually on medications to treat symptoms of allergic reactions. But at least one small biotechnology company is hoping to make this market disappear. Nancy and Tse Wen Chang and their Houston company, Tanox Biosystems Inc., appear to be front-runners in this first leg of a race to creat

Genetic engineers at Crop Genetics and Mycogen place hopes on two different strategies for pest control Like Babe Ruth, John Henry sees himself as a slugger. The president and CEO of Crop Genetics International of Hanover, Md., Henry is going for a grand slam in his field of pest control: a genetically designed biopesticide against the European corn borer, a pest that munches $500 million worth of corn annually in the United States. In contrast to his heavy-hitting strategy are the efforts of